Skip to content

Effect of Unani medicine in treatment of Quba (tinea corporis and cruris)

A Randomized Clinical Trial to Evaluate the Safety and Efficacy of Unani Pharmacotherapy (Barg-i-Shahatra Orally and Tukhm-i Panwad mixed with Sugarcane Sirka Locally) with and without Leech Therapy Versus Standard Therapy (Oral Terbinafine and 1 percent Clotrimazole Cream) in Quba (Tinea cruris and corporis) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112730
Enrollment
69
Registered
2026-06-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

Intervention1: Barg-i-Shahatra Orally and Tukhm-i Panwad mixed with Sugarcane Sirka Locally) with and without Leech Therapy: Barg-i-Shahatra 10 grams to be soaked overnight in 200 mL water boiled in m

Sponsors

State Unani Medical College and HAHRDM Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically as well as KOH and mycological culture positive cases of Quba (tinea corporis and cruris). Patients who provide written informed consent to participate and willing to adhere to the protocol.

Exclusion criteria

Exclusion criteria: Pregnant and breastfeeding women. Patients suffering from serious systemic illnesses. Patients diagnosed with other dermatological conditions, such as eczema, psoriasis which may mimic or overlap with Quba. Other type of tinea. Patients with secondary bacterial infection (e.g., pyoderma) over the fungal lesions. Patients who were on antifungal or steroid therapy in the last week before entry in study.

Design outcomes

Primary

MeasureTime frame
Change in KOH wet mount test Change in mycological culture Change in pruritus measured on VAS Change in erythema, peripheral raised margin with central clearing, and diameter of lesions (in cm) measured on Likert ScaleTimepoint: baseline, 7 day, 14 day, 28 day, 42 day and 60 day

Secondary

MeasureTime frame
Change in Dermatology Life Quality Index (DLQI) Change in Investigator s Static Global Assessment Clinical photographyTimepoint: baseline, 28 day and 60 day

Countries

India

Contacts

Public ContactDr Mohd Khalid

Mahayogi Guru Gorakhnath Ayush University Gorakhpur

vc@mggaugkp.in05512989819

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026